Skip to content
August 28, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Genomics and Precision Medicine
  • A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press
  • Genomics and Precision Medicine

A New Era for Genomic Science: ASHG Announces Strategic Publishing Partnership with Oxford University Press

Siti Muinah August 28, 2026 7 minutes read
a-new-era-for-genomic-science-ashg-announces-strategic-publishing-partnership-with-oxford-university-press-3

ROCKVILLE, MD – In a significant development for the global scientific community, the American Society of Human Genetics (ASHG) has officially announced a new strategic partnership with Oxford University Press (OUP). Beginning in January 2027, this collaboration will see OUP take over the production and dissemination of the Society’s two prestigious journals: The American Journal of Human Genetics (AJHG) and the open-access publication Human Genetics and Genomics Advances (HGG Advances).

This transition marks a pivotal shift for the ASHG, which represents nearly 8,000 researchers, clinicians, and genetic counselors worldwide. By aligning with one of the world’s most established academic publishers, the Society aims to amplify the reach of its scientific output while safeguarding the rigorous peer-review processes that have defined its reputation for over three-quarters of a century.


The Core Agreement: Maintaining Editorial Integrity

At the heart of the announcement is the preservation of ASHG’s editorial autonomy. While OUP will manage the logistical, technical, and distribution aspects of the journals, the Society retains full, unwavering control over editorial decisions and peer review.

This distinction is vital in the modern publishing landscape, where the pressure to monetize research can sometimes conflict with academic integrity. By maintaining internal control over editorial policy, ASHG ensures that its journals will continue to be guided by the scientists who understand the nuances of the field, rather than external commercial interests. This move reinforces the Society’s commitment to "scientific excellence, rigor, and integrity," as noted in their official release.


Chronology: A Legacy of Discovery

To understand the significance of this transition, one must look at the historical trajectory of ASHG’s publications.

The Foundation of AJHG (1948–Present)

For over 75 years, The American Journal of Human Genetics has served as the bedrock of the discipline. Since its inception in 1948, AJHG has been the primary vehicle for the most influential discoveries in the field. From the early mapping of human chromosomes to the modern era of high-throughput sequencing and gene-editing technologies, the journal has documented the rapid evolution of our understanding of the human genome.

The Expansion into Open Access (2020)

As the field of genomics accelerated, the need for a more flexible, open-access platform became apparent. In 2020, ASHG launched Human Genetics and Genomics Advances (HGG Advances). This journal was designed to cater to the rapid publication of diverse research formats, ranging from technical reports to broad genomic surveys, all while adhering to the same high standards of scientific validity and reproducibility that characterize AJHG.

The 2027 Pivot

The transition to Oxford University Press represents the third major act in this timeline. Following decades of growth, ASHG identified the need for a partner with the infrastructure to navigate the increasingly complex global digital landscape of academic publishing. The decision, finalized in July 2024, sets the stage for a two-year preparation period before the official handover in early 2027.


Supporting Data: The Power of the Partnership

The choice of Oxford University Press is rooted in OUP’s extensive experience and global footprint. As the largest university press in the world, OUP brings a wealth of data-backed capabilities to the table.

  • Breadth of Experience: OUP publishes over 500 academic and research journals. Notably, 75% of these are published in partnership with learned societies, mirroring the model established with ASHG.
  • Historical Longevity: With over 500 years of publishing history, OUP offers a stability that few other publishers can match.
  • Global Reach: By leveraging OUP’s sophisticated distribution networks, ASHG anticipates an increase in the discoverability of its content, particularly in emerging markets where genomic research is rapidly expanding but access to traditional journals has historically been limited.

The partnership also addresses the logistical challenges of modern digital dissemination—ensuring that research is not only published but is also discoverable, archivable, and compliant with the evolving international standards for Open Science.


Official Responses: Aligning Missions

The transition has been met with enthusiasm from both the Society and the Press.

ASHG Perspective

"This partnership marks an exciting new chapter for ASHG’s journals and the communities they serve," said ASHG President Susan A. Slaugenhaupt, PhD. "OUP’s deep publishing expertise, global reach, and strong support for society journals will help us expand the visibility and impact of the research we publish while maintaining the editorial independence and scientific standards that are central to ASHG’s mission."

Dr. Slaugenhaupt’s comments emphasize that the transition is not merely about logistics; it is about growth. By offloading the operational burden of publishing, the Society can focus its resources on its core mission: advocacy, professional development, and promoting responsible genomic policy.

OUP Perspective

Jennifer Paxton-Boyd, Publishing Director for Science at OUP, echoed this sentiment, noting, "Oxford University Press is delighted to collaborate with ASHG to publish its prestigious journals. We look forward to working with the Society and editors to broaden the reach of their high-quality research, support the Society’s mission, and serve the global human genetics and genomics community."

For OUP, the inclusion of ASHG’s journals in their portfolio is a strategic win, adding two of the most cited and respected journals in the life sciences to their collection.


Implications for the Scientific Community

The shift in publishers will have several ripple effects for the international community of geneticists, clinicians, and educators.

1. Enhanced Accessibility

A primary goal of this transition is the improvement of content accessibility. In an era where "Open Science" is becoming the gold standard, the partnership is expected to strengthen the presence of HGG Advances while maintaining the prestige of the subscription-based AJHG. Researchers in the Global South, in particular, may benefit from OUP’s initiatives regarding equitable access and digital dissemination.

2. Streamlined Publishing Experience

Authors who submit to ASHG journals can expect a modernized submission and review experience. OUP’s platform is known for its user-friendly interface and robust tracking systems, which are designed to reduce administrative friction for researchers—a constant pain point in the academic publishing cycle.

3. Sustainability and Longevity

For a learned society like ASHG, the financial sustainability of its journals is critical. These publications provide the primary revenue stream that funds the Society’s advocacy efforts, educational workshops, and the massive undertaking of the annual ASHG meeting. By partnering with a non-profit university press, the Society ensures that the revenue generated by its intellectual output is reinvested back into the community rather than into private equity.

4. A Template for Society-Led Publishing

The ASHG-OUP model may serve as a template for other professional societies. As commercial publishing giants face scrutiny for high subscription fees and restrictive copyright policies, the movement toward society-university press partnerships—which prioritize academic mission over corporate dividends—is gaining momentum.


Looking Toward 2027

As the transition period commences, the focus for both ASHG and OUP will be on continuity. For the authors and readers of AJHG and HGG Advances, the day-to-day experience of engaging with the research is expected to remain seamless.

However, beneath the surface, the infrastructure of these journals will undergo a significant upgrade. By combining the cutting-edge genomic research curated by ASHG with the centuries-old expertise of Oxford University Press, the scientific community can look forward to a more robust, accessible, and influential future for human genetics literature.

The coming months will likely see further announcements regarding the integration of workflows and the specific digital tools that will be available to authors. For now, the scientific community can be assured that the stewards of human genetics research are positioning themselves to meet the challenges of the next half-century with renewed vigor and a clear, mission-driven strategy.

About the Author

Siti Muinah

Author

View All Posts

Post navigation

Previous: Verrica Pharmaceuticals Completes Enrollment in Pivotal COVE-2 Trial for Ycanth in Common Warts, Anticipating Key Data in Early 2027
Next: Pioneering the Future of Precision Medicine: The Scientific Odyssey of Dr. Sarra Merzouk

Related Stories

pioneering-the-future-of-precision-medicine-the-scientific-odyssey-of-dr-sarra-merzouk
  • Genomics and Precision Medicine

Pioneering the Future of Precision Medicine: The Scientific Odyssey of Dr. Sarra Merzouk

Reynand Wu August 28, 2026
from-classroom-curiosity-to-genomic-triumph-the-story-of-bruce-and-the-wiregrass-peanut-project
  • Genomics and Precision Medicine

From Classroom Curiosity to Genomic Triumph: The Story of "Bruce" and the Wiregrass Peanut Project

Nana August 28, 2026
the-infinite-dish-how-harvard-scientists-shattered-the-longevity-barrier-in-brain-organoid-research
  • Genomics and Precision Medicine

The Infinite Dish: How Harvard Scientists Shattered the Longevity Barrier in Brain Organoid Research

Dwi Wanna August 28, 2026

Recent Posts

  • Shedding Light on the "Black Box": Analyzing the First Year of Mandatory Prior Authorization Reporting
  • Advocacy in Action: METAvivor Calls on Congress to Secure Future of National Cancer Registries
  • Beyond the Six-Pack: Redefining Core Strength for Functional Longevity
  • The 2026 Biotech Funding Landscape: A Deep Dive into the Industry’s Most Well-Funded Private Innovators
  • Kardium Secures C$31.25M Government Funding to Scale Revolutionary Globe Pulsed Field Ablation System

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

shedding-light-on-the-black-box-analyzing-the-first-year-of-mandatory-prior-authorization-reporting
  • Breast Cancer Legislation and Policy

Shedding Light on the "Black Box": Analyzing the First Year of Mandatory Prior Authorization Reporting

Basiran August 28, 2026
advocacy-in-action-metavivor-calls-on-congress-to-secure-future-of-national-cancer-registries
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Calls on Congress to Secure Future of National Cancer Registries

Laily UPN August 28, 2026
beyond-the-six-pack-redefining-core-strength-for-functional-longevity
  • Integrative Oncology and Holistic Care

Beyond the Six-Pack: Redefining Core Strength for Functional Longevity

Iffa Jayyana August 28, 2026
the-2026-biotech-funding-landscape-a-deep-dive-into-the-industrys-most-well-funded-private-innovators
  • Treatment Innovations

The 2026 Biotech Funding Landscape: A Deep Dive into the Industry’s Most Well-Funded Private Innovators

Nana August 28, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.